The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to screen for colon cancer. The test isn't meant to replace colonoscopies, but is generating enthusiasm ...

Dr. Bethany Malone has treated a lot of colorectal cancer patients. The youngest, not counting those with genetic conditions, was 19 years old.Colorectal cancer used to be considered a cancer of older ...

Huntsman Cancer Institute recommends all individuals start regular colorectal cancer screenings at age 45. Colorectal cancer screenings help detect colon and rectal cancer early when it is easier to ...

The first blood test to screen for colorectal cancer could be approved this year — raising the potential to drastically increase the number of people diagnosed with the second-highest cause of cancer ...

Cases of colorectal cancer in younger adults are climbing worldwide, driven by lifestyle changes and inherited genetic risks.

Colorectal cancer was once considered primarily a disease of aging. But rates are now on the rise among younger adults. Since 2011, colon cancer rates among people younger than 50 have increased by ...

According to Cologuard, made by Wisconsin-based Exact Sciences, there are three primary reasons why you may receive a testing ...

INDIANAPOLIS (WISH) – This week, the United States Food and Drug Administration approved Guardant’s Shield blood test to screen for colon cancer in average-risk Americans 45 to 75 years old.

Colon cancer remains a significant health concern, particularly within the Black community, where the disease disproportionately affects individuals. A recent study led by researcher Adjoa ...

Colonoscopy is the gold standard for detecting colon cancer, but every year about 50 million people in the U.S. who qualify for a colonoscopy don't get it done, according to the American Cancer ...

Military members and veterans can be at a disadvantage in getting screenings that can spot pre-cancerous growths and provide earlier diagnoses.